IndraLab

Statements


| 2

reach
"Our current study shows that NF-kappaB1 is significantly suppressed by LBH589 treatment, similar to that reported previously in colon cancer [XREF_BIBR]."

reach
"In the current study, we focused on elucidating the mechanism underlying LBH589 's effects on AI resistant cell lines, and showed that LBH589 inhibits the NF-kappaB1 pathway."